Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Methods in Molecular Biology (Clifton, N.J.)|June 15, 2015
Aptamer Targeting the ERBB2 Receptor Tyrosine Kinase for Applications in Tumor TherapyGeorg Mahlknecht, Michael Sela, Yosef YardenThe Journal of Membrane Biology|June 15, 2007
Measuring the osmotic water permeability of the plant protoplast plasma membrane: implication of the nonosmotic volumeAniela Sommer, Georg Mahlknecht, Gerhard ObermeyerBiochemical and Biophysical Research Communications|August 7, 2015
Multimerization of ERBB2/HER2 specific aptamer leads to improved receptor bindingGeorg Mahlknecht, Ruth Maron, Bilha Schechter, et al.Proceedings of the National Academy of Sciences of the United States of America|May 1, 2013
Aptamer to ErbB-2/HER2 enhances degradation of the target and inhibits tumorigenic growthGeorg Mahlknecht, Ruth Maron, Maicol Mancini, et al.Proceedings of the National Academy of Sciences of the United States of America|September 5, 2013
Inhibition of pancreatic carcinoma by homo- and heterocombinations of antibodies against EGF-receptor and its kin HER2/ErbB-2Ruth Maron, Bilha Schechter, Maicol Mancini, et al.Translational Oncology|October 4, 2011
Simultaneous Inhibition of Estrogen Receptor and the HER2 Pathway in Breast Cancer: Effects of HER2 AbundanceAnna Emde, Georg Mahlknecht, Kerstin Maslak, et al.International Immunology|May 24, 2011
Generation and characterization of peptide mimotopes specific for anti ErbB-2 monoclonal antibodiesEsther J Witsch, Georg Mahlknecht, Jean Wakim, et al.EMBO Molecular Medicine|December 8, 2017
An oligoclonal antibody durably overcomes resistance of lung cancer to third-generation EGFR inhibitorsMaicol Mancini, Hilah Gal, Nadège Gaborit, et al.Pageof 1